These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 8750276

  • 1. Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone marrow transplantation for Philadelphia-chromosome positive chronic myelogenous leukemia.
    Elmaagacli AH, Becks HW, Beelen DW, Stockova J, Bützler R, Opalka B, Schaefer UW.
    Bone Marrow Transplant; 1995 Dec; 16(6):823-9. PubMed ID: 8750276
    [Abstract] [Full Text] [Related]

  • 2. Persistent donor chimaerism is consistent with disease-free survival following BMT for chronic myeloid leukaemia.
    Gardiner N, Lawler M, O'Riordan J, DeArce M, Humphries P, McCann SR.
    Bone Marrow Transplant; 1997 Aug; 20(3):235-41. PubMed ID: 9257892
    [Abstract] [Full Text] [Related]

  • 3. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J, Serrano J, Jiménez A, Castillejo JA, Reina ML, González MG, Rodríguez MC, García I, Sánchez J, Maldonado J, Torres A.
    Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
    [Abstract] [Full Text] [Related]

  • 4. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Mackinnon S, Barnett L, Heller G.
    Bone Marrow Transplant; 1996 Apr; 17(4):643-7. PubMed ID: 8722369
    [Abstract] [Full Text] [Related]

  • 5. Molecular studies of chimerism and minimal residual disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation.
    Elmaagacli AH, Beelen DW, Becks HW, Mobascher A, Stockova J, Trzensky S, Opalka B, Schaefer UW.
    Bone Marrow Transplant; 1996 Aug; 18(2):397-403. PubMed ID: 8864452
    [Abstract] [Full Text] [Related]

  • 6. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G, Hernandez A, Heyll A, Wolf HH, Wernet P.
    Cancer Detect Prev; 1996 Aug; 20(6):601-9. PubMed ID: 8939346
    [Abstract] [Full Text] [Related]

  • 7. Detection of bcr/abl transcripts by RT-PCR and their colorimetric evaluation in chronic myeloid leukemia patients receiving allogeneic bone marrow transplantation.
    Santini V, Zoccolante A, Bosi A, Guidi S, Saccardi R, Vannucchi AM, Martinazzo G, Bernabei PA, Ferrini PR.
    Haematologica; 1996 Aug; 81(3):201-7. PubMed ID: 8767524
    [Abstract] [Full Text] [Related]

  • 8. Durable molecular remission in a patient with chronic myelogenous leukemia and host-derived hematopoiesis after allogeneic bone marrow transplantation.
    Wakui M, Okamoto S, Ishida A, Tanosaki R, Mori T, Kawai Y, Ohshima S, Ikeda Y.
    Bone Marrow Transplant; 1996 Oct; 18(4):801-4. PubMed ID: 8899199
    [Abstract] [Full Text] [Related]

  • 9. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
    Elmaagacli AH, Runkel K, Steckel N, Opalka B, Trenschel R, Seeber S, Schaefer UW, Beelen DW.
    Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437
    [Abstract] [Full Text] [Related]

  • 10. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G, Roy DC, Gonin R, Alyea EP, Bélanger R, Gyger M, Perreault C, Bonny Y, Lerra I, Murray C.
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [Abstract] [Full Text] [Related]

  • 11. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
    Elmaagacli AH, Beelen DW, Kroll M, Trzensky S, Stein C, Schaefer UW.
    Bone Marrow Transplant; 1998 Jan; 21(2):159-66. PubMed ID: 9489633
    [Abstract] [Full Text] [Related]

  • 12. Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells.
    Verdonck LF, Petersen EJ, Lokhorst HM, Nieuwenhuis HK, Dekker AW, Tilanus MG, de Weger RA.
    Bone Marrow Transplant; 1998 Dec; 22(11):1057-63. PubMed ID: 9877267
    [Abstract] [Full Text] [Related]

  • 13. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia.
    Zetterquist H, Mattsson J, Uzunel M, Näsman-Björk I, Svenberg P, Tammik L, Bayat G, Winiarski J, Ringdén O.
    Bone Marrow Transplant; 2000 Apr; 25(8):843-51. PubMed ID: 10808205
    [Abstract] [Full Text] [Related]

  • 14. Increasing mixed haematopoietic chimaerism after BMT with total depletion of CD4+ and partial depletion of CD8+ lymphocytes is associated with a higher incidence of relapse.
    Serrano J, Román J, Herrera C, Castillejo JA, Navarro JA, Reina ML, González MG, Rodriguez MC, Pascual A, Sánchez J, Torres A.
    Bone Marrow Transplant; 1999 Mar; 23(5):475-82. PubMed ID: 10100562
    [Abstract] [Full Text] [Related]

  • 15. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 16. [Bone marrow transplantation in chronic myeloid leukemia].
    Milone JH, Bordone J, Etchegoyen O, Napal J, Prates MV, Morales VH.
    Medicina (B Aires); 1999 Apr; 59(1):1-10. PubMed ID: 10349111
    [Abstract] [Full Text] [Related]

  • 17. Autologous reconstitution with BCR-ABL-negative haematopoiesis after T cell-depleted allogeneic BMT for CML.
    Serrano J, Román J, Castillejo JA, Sánchez J, Navarro JA, Martín C, Herrera C, Torres A.
    Bone Marrow Transplant; 1998 Sep; 22(6):599-601. PubMed ID: 9758352
    [Abstract] [Full Text] [Related]

  • 18. Eosinophilia after allogeneic bone marrow transplantation using the busulfan and cyclophosphamide preparative regimen.
    Kalaycioglu ME, Bolwell BJ.
    Bone Marrow Transplant; 1994 Jul; 14(1):113-5. PubMed ID: 7951097
    [Abstract] [Full Text] [Related]

  • 19. Donor chimaerism is a strong indicator of disease free survival following bone marrow transplantation for chronic myeloid leukaemia.
    Gardiner N, Lawler M, O'Riordan J, De'Arce M, McCann SR.
    Leukemia; 1997 Apr; 11 Suppl 3():512-5. PubMed ID: 9209441
    [Abstract] [Full Text] [Related]

  • 20. [Study of the time course of mixed chimerism by fluorescent in situ hybridization in patients with chronic myeloid leukemia after allogenic transplantation of bone marrow].
    Vinogradova OA, Savchenko VG, Neverova AL, Diachenko LV, Domracheva EV, Liubimova LS, Mendeleeva LP.
    Ter Arkh; 2001 Apr; 73(7):26-34. PubMed ID: 11523405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.